Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

Despite the great efforts for better treatment options for diffuse large B-cell lymphoma (DLBCL) (most common form of non-Hodgkin lymphoma, NHL) to treat and prevent relapse, it continues to be a challenge. Here, we present an overview of DLBCL and address the diagnostic assays and molecular techniq...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Lodhi, Niraj, Tun, Moe, Nagpal, Poonam, Inamdar, Arati A., Ayoub, Nehad M., Siyam, Noor, Oton-Gonzalez, Lucia, Gerona, Angela, Morris, Dainelle, Sandhu, Rana, Suh, Kwangsun Stephen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646825/
https://ncbi.nlm.nih.gov/pubmed/33216822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27785
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi